MAPT and Alzheimer disease: Cholinesterase inhibitors and memantine have been acknowledged as approved drug treatments for AD, while anti-amyloid therapy, immunization, monoclonal antibodies and tau-targeted therapy are considered as potential future drug treatments [5].